Delivery Order SPE2DB22D3016-SPE2DB25FBGU8
Award Date 8/29/25
Potential Completion Date 9/2/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5ml syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $9,404.28 under a firm fixed-price arrangement, with performance to be completed by September 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $1,865.25 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a transactional...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $133,843.21 on August 12, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is executed under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price delivery order, valued at $2,807.39, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 31, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, valued at $7,077.10 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 20, 2025, and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,330.50 with an ultimate completion date of August 21, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,342.46 for Boostrix TDAP vaccine in 0.5mL syringe format on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, valued at $18,399.97 with a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 19, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small component of the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5 mL syringes, with a contract value of $9,228.10. This firm fixed-price delivery order, issued on August 25, 2025, represents a non-competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is AmerisourceBergen's...